Melissa Adams: Daily

L4VA and Toto Finance launch a silver-backed token on Cardano, testing the appetite for physical assets in DeFi. Is this the key to unlocking trillions in value?

MEXC's latest audit reveals a staggering 288% Bitcoin reserve, setting a high bar for transparency. But as it builds a financial fortress, user complaints raise a critical question: is on-chain proof enough?

Binah Capital Group swings from a loss to a profit in Q2, crediting its unique model for empowering independent advisors. Is this a fluke or a new industry benchmark?

Premium home brand Serena & Lily secures a major lending facility from Oxford Finance, signaling a strategic push to expand its physical Design Shops.

New US tariffs on polysilicon are set to redefine the solar industry, shifting the market's calculus from the lowest price to the most secure supply chain.

abrdn's latest CEF distributions promise steady income, but a closer look reveals a complex web of 'return of capital' and managed policies. Here's what investors need to know.

Longshot's kinetic launch system earns a fast-track procurement status from DARPA, promising to reshape hypersonic testing and national security strategy.

A Nashville agency's debut on the Inc. 5000 reveals a powerful lesson: in a world of endless choice, deep specialization in complex markets is the key to growth.

A landmark deal brings non-alcoholic beer to MetLife Stadium, signaling a seismic shift in fan culture and a brilliant strategic play by a market leader.

Fisent Technologies just secured $4.3M to solve GenAI’s biggest problem in regulated industries: trust. Here’s how they plan to do it.

Singapore's NUH just earned a top global green ranking. We go beyond the award to uncover the strategic blueprint that makes sustainability a core part of healing.

A bureaucratic blunder in Florida's Medicaid funding has ignited a legal battle, leaving millions of families fearing the loss of their children's doctors.

Dr. Kristy Lee's third 'Top Dentist' win is more than a local honor. It's a case study in the fight for independent, patient-first care in an era of corporate dentistry.

As Texas regulators pump the brakes on the state's AI gold rush, Hut 8 Corp. positions itself as a model citizen. But can one company's playbook solve the grid's growing pains?

Members Trust Company's appointment of Anna Weyl is more than a new hire; it's a strategic play for the complex world of ultra-high-net-worth clients.

A Utah biotech's new blood test can identify the exact brain cells dying in diseases like Alzheimer's, a major leap beyond today's diagnostics.

The American Society of Hematology names insider Matthew Gertzog as CEO, succeeding a 30-year leader. The move ensures continuity while prioritizing data-driven research.

The cannabis giant posts strong Q1 growth and nears profitability, but a widening cash outflow reveals the tough road ahead in a maturing global market.

An industrial automation leader wins a top award not for a new machine, but for a system that supports employee health, youth education, and community well-being.

Beyond the numbers, a record 210 organ transplants in July reveals a high-tech, human-powered system rewriting the rules of saving lives.